The Posttraumatic Stress Disorder Checklist (PCL-5; Weathers et al., 2013) was recently revised to reflect the changed diagnostic criteria for PTSD in the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5; American Psychiatric Association, 2013). We investigated the psychometric properties of PCL-5 scores in a large cohort (N = 912) of military service members seeking PTSD treatment while stationed in garrison. We examined the internal consistency, convergent and discriminant validity, and DSM-5 factor structure of PCL-5 scores, their sensitivity to clinical change relative to PTSD Symptom Scale -Interview (PSS-I; Foa, Riggs, Dancu, & Rothbaum, 1993) scores, and their diagnostic utility for predicting a PTSD diagnosis based on various measures and scoring rules. PCL-5 scores exhibited high internal consistency. There was strong agreement between the order of hypothesized and observed correlations among PCL-5 and criterion measure scores. The best-fitting structural model was a 7-factor hybrid model , which demonstrated closer fit than all other models evaluated, including the DSM-5 model. The PCL-5's sensitivity to clinical change, pre-to posttreatment, was comparable to that of the PSS-I. Optimally efficient cut scores for predicting PTSD diagnosis were consistent with prior research with service members (Hoge, Riviere, Wilk, Herrell, & Weathers, 2014) . The results indicate that the PCL-5 is a psychometrically sound measure of DSM-5 PTSD symptoms that is useful for identifying provisional PTSD diagnostic status, quantifying PTSD symptom severity, and detecting clinical change over time in PTSD symptoms among service members seeking treatment. scores. Because most participants in our cohort were treated for PTSD, we also examined the extent to which PCL-5 scores indexed change. In addition, to assist clinicians and researchers who plan to use the PCL-5 as a repeated measure of change, we derived PCL-5 cut scores that would indicate clinically meaningful symptom improvement or exacerbation among service members treated for PTSD. Finally, we calculated optimally efficient cut scores on the PCL-5 that corresponded to diagnostic cut scores on a DSM-IV-based clinical interview and the PCL-S.
consistency in samples of war veterans (α = .95; Pietrzak et al., 2015) as well as civilians (α = .95; Armour et al., 2015) . Evidence for construct validity has likewise been encouraging but limited in scope. In a large cohort of U.S. Army Soldiers, total PCL-5 scores were associated with reports of depression (r = .73) and generalized anxiety (r = .79) as well as greater functional impairment (rs ranging from .31 to .59; Hoge, Riviere, Wilk, Herrell, & Weathers, 2014) . In a civilian sample of undergraduates with exposure to potentially traumatic events, scores on the four DSM-5 subcomponents of the PCL-5 were associated with depressive symptoms (rs ranging from .48 to .78; Biehn et al., 2013) . Other studies evaluating the convergent and discriminant validity of PCL-5 scores have used factor structures deviating from the DSM-5 Tsai et al., 2015) , rendering unclear what can be generalized from these efforts.
Most prior investigations of the PCL-5 have focused on testing the validity of the DSM-5
factor structure, with highly variable results. A study of war veterans enrolled in an online intervention reported adequate fit and temporal stability of the DSM-5 structure (Keane et al., 2014) . A study with undergraduate students also found support for the DSM-5 model compared to a four-factor model that combines emotional numbing and hyperarousal into a Dysphoria factor (Biehn et al., 2013) . On the other hand, in a sample of Chinese earthquake survivors, a sixfactor model--dividing Criterion D into negative affect and anhedonia components and Criterion E into anxious arousal and dysphoric arousal components--best fit the data (Liu et al., 2014) . In addition, analyses of a large, nationally representative sample of veterans found support for a seven-factor model that includes negative affect, anhedonia, anxious arousal, dysphoric arousal, and externalizing behaviors symptom clusters Pietrzak et al., 2015) .
In the only published study examining the clinical impact and utility of the PCL-5 in military personnel, Hoge and colleagues (2014) compared the PCL-5 with the DSM-IV specific stressor version of the PCL (PCL-S; Weathers et al., 1993) in a large sample of U.S. Army Soldiers. Although the PCL-5 and PCL-S showed a high degree of agreement in identifying PTSD cases (kappa = .67), Hoge et al. found substantial discordance between the measures; 30% of Soldiers who met criteria for PTSD on the PCL-S did not meet criteria on the PCL-5, and 27% who met criteria on the PCL-5 did not meet criteria on the PCL-S. The investigators also identified optimally efficient cut scores on the PCL-5 that corresponded to empirically derived cut scores on the PCL-S indicating a positive screen for PTSD.
Prior evaluations of the PCL-5 have thus focused on factor structure or comparison of diagnostic criteria and have not comprehensively analyzed the psychometric characteristics of the measure. We conducted a psychometric evaluation of PCL-5 scores in a sample of service members seeking treatment for deployment-related PTSD in the context of randomized controlled psychotherapy trials within the South Texas Research Organizational Network Guiding Studies on Trauma and Resilience (STRONG STAR) consortium. We evaluated the internal consistency, convergent and discriminant validity, and structural validity of PCL-5 scores. Because most participants in our cohort were treated for PTSD, we also examined the extent to which PCL-5 scores indexed change. In addition, to assist clinicians and researchers who plan to use the PCL-5 as a repeated measure of change, we derived PCL-5 cut scores that would indicate clinically meaningful symptom improvement or exacerbation among service members treated for PTSD. Finally, we calculated optimally efficient cut scores on the PCL-5 that corresponded to diagnostic cut scores on a DSM-IV-based clinical interview and the PCL-S.
Method

Participants and Procedure
Participants were military service members and recently retired veterans recruited, assessed, and treated at the Carl R. Darnall Army Medical Center at Fort Hood, Texas, under the auspices of the STRONG STAR Consortium. We combined data from three clinical trials in the consortium. Recruitment was based on referrals by providers and self-referrals by service members. Prescreening criteria included: active duty service member status, deployed in support of Iraq and/or Afghanistan wars, aged 18 to 65, willing to participate in the format of treatments used in the research, available for the duration of the study, and no recent medication changes.
To ensure the presence of non-cases in our sample, we included participants (n = 147) who completed baseline measures after consenting to participate but were not randomized into a trial (and thus did not complete follow-up measures) because they did not meet diagnostic criteria for PTSD on the PTSD Symptom Scale -Interview version (PSS-I; Foa, Riggs, Dancu, & Rothbaum, 1993) . The results of this study will therefore be chiefly generalizable to treatmentseeking military personnel. Participants were not compensated for their involvement in the study. King, King, Vogt, Knight, & Samper, 2006) . Independent evaluators guided each participant in selecting the most distressing event of those identified on these forms. For service members randomized into a clinical trial, the same instruments were also administered in the same order two weeks after the end of treatment. A sample of 912 participants completed the PCL-5 as well as the PCL-S and PSS-I at baseline.
Additional measures that were used to assess discriminant validity of PCL-5 scores were available for subsamples of these participants.
Measures
Demographics. A demographics form measured race, gender, age, education, military service information (e.g., military grade), and other participant characteristics (see Table 1 ).
PCL-5.
The PCL-5 is a 20-item self-report measure that evaluates the degree to which an individual has been bothered in the past month by DSM-5 PTSD symptoms tied to his or her most currently distressing event (Weathers et al., 2013) . Items are rated from 0 ("not at all") to 4 ("extremely") and are summed for a total severity score. Subscale severity scores are calculated by summing items in each of the four DSM-5 PTSD symptom clusters: intrusions (Items 1-5), avoidance (Items 6-7), negative alterations in cognitions and mood (NACM; Items 8-14), and alterations in arousal and reactivity (AR; Items 15-20). PTSD caseness was defined as endorsing a severity of at least a 2 ("moderate") for a sufficient number of symptoms in each cluster to meet DSM-5 criteria. At the time this study began, only a draft version of the PCL-5 was available. Minor wording differences between the version of the PCL-5 used in this study and the currently-published version are described in Supplemental Material. Internal consistency reliabilities in this study for the PCL-5 and all measures enumerated in the following section are shown in Table 2 .
Measures used to assess convergent and discriminant validity.
PCL-S.
The PCL-S is a 17-item self-report measure that evaluates the degree to which an individual has been bothered in the past month by DSM-IV PTSD symptoms tied to a specific life event (Weathers et al., 1993) . Items are rated from 1 ("not at all") to 5 ("extremely") and are summed for a total severity score. Subscale severity scores are calculated by summing items in each of the three DSM-IV PTSD symptom clusters: intrusions (Items 1-5), avoidance/emotional numbing (Items 6-12), and arousal (Items 12-17). Additionally, to permit comparison with the PCL-5 items capturing the revised DSM-5 Criterion C, a strategic avoidance subscale was calculated by summing Items 6 and 7. PCL-S scores have shown high internal consistency and strong convergent validity in military samples (Wilkins, Lang, & Norman, 2011) . Caseness on the PCL-S was defined as endorsing a severity of at least a 3 ("moderate") for a sufficient number of symptoms in each cluster to meet DSM-IV criteria. Of the three versions of the PCL developed for DSM-IV, the PCL-S and PCL-5 most closely resemble each other because they contain an instructional prompt to respond to items in the context of a specific life event. The 
PSS-I.
The PSS-I is a 17-item clinical interview that evaluates DSM-IV PTSD symptoms on a single dimension combining frequency and severity in the last two weeks (Foa et al., 1993) .
PSS-I scores have been shown to be highly correlated with scores on the Clinician Administered PTSD Scale (Blake et al., 1995) , which takes longer to administer (Foa & Tolin, 2000) . Items are scored on a scale ranging from 0 ("not at all") to 3 ("very much") and are summed for a total severity score. Subscale severity scores are calculated by summing items in each of the DSM-IV PTSD symptom clusters, as described in this section for the PCL-S. Additionally, to permit comparison with the PCL-5 items capturing the revised DSM-5 Criterion C, a strategic avoidance subscale was calculated by summing Items 6 and 7. PSS-I scores have shown high internal consistency and strong convergent validity in civilian samples (Foa et al., 1993; Foa & Tolin, 2000) . PTSD caseness on the PSS-I was calculated in two ways. First, as recommended by the scale developers, symptoms were rated as present if they were scored at least a 1 ("a little"), and caseness was defined as the presence of a sufficient number of symptoms in each cluster to meet DSM-IV criteria (Foa et al., 1993) . Second, we generated a more stringent case definition, matching the PCL-based decision rule, requiring a severity of at least a 2 ("somewhat") for the requisite number of symptoms to meet DSM-IV criteria.
Warzone exposure. The Combat Experiences and Aftermath of Battle subscales of the DRRI (King et al., 2006) were modified so that the items asked only about whether the individual faced exposure to various stressors himself or herself, rather than asking whether the individual or members of his or her unit had been exposed. Additionally, eight items were added to the Combat subscale, assessing events likely to have been encountered in the Iraq and Afghanistan wars (see Vasterling et al., 2010) . Responses to all items were given on a scale ranging from 1 ("never") to 5 ("daily or almost daily"), and scores were summed to create total Combat Experiences and Aftermath of Battle severity scores (see Vogt, Proctor, King, King, & Vasterling, 2008 and Vogt, Smith, King, & King, 2012) . Scores on these subscales have shown high internal consistency and strong concurrent and discriminant validity in veterans of the war in Iraq (Vogt et al., 2008) .
Anxiety symptoms. The Beck Anxiety Inventory (BAI; Beck, Epstein, Brown, & Steer, 1988 ) is a 21-item self-report measure that asks respondents to rate the extent to which they have been bothered by anxiety symptoms within the past week on a scale ranging from 0 ("not at all") to 3 ("severely"). Scores are summed to obtain a total severity score. BAI scores have shown high internal consistency and good convergent and discriminant validity in civilian samples (Beck et al., 1988) .
Depression symptoms. The Beck Depression Inventory II (BDI-II; Beck, Steer, & Brown, 1996 ) is a 21-item self-report measure that assesses symptoms of depression. For each item, respondents choose one of four statements representing various levels of symptom severity over the past two weeks; the statements are scaled from 0 (no disturbance) to 3 (maximal disturbance). Scores are summed to obtain a total severity score. BDI scores have shown high internal consistency and good convergent and discriminant validity in civilian samples (Beck et al., 1996) .
Guilt. The Trauma-Related Guilt Inventory (TRGI) is a self-report measure of guiltrelated cognitions and distress (Kubany et al., 1996) . Whereas the original scale includes 32 items tied to a specific traumatic experience, we used an abbreviated 16-item version tied to combat and operational experiences generally. Items are rated from 0 ("not at all true") to 4 ("extremely true") and summed into three subscales: Hindsight-Bias/Responsibility, Wrongdoing, and Lack of Justification. Scores on the TRGI subscales have shown moderate to high internal consistency, strong convergent validity with trait measures of guilt, and good discriminant validity with age and education in a sample of Vietnam veterans (Kubany et al., 1996) .
Anger. The State-Trait Anger Expression Inventory-2 (STAXI-2; Spielberger, 1999) State Anger subscale is a 15-item self-report measure of the extent to which an individual currently feels or wishes to express anger. Items are rated on a scale ranging from 1 ("not at all") to 4 ("very much so") and are summed to create an overall intensity score. Scores on the STAXI-2 have shown high internal consistency and strong convergent validity in civilian samples (Spielberger, 1999) , and scores on the original STAXI have shown high internal consistency in a
Vietnam veteran sample (Taft, Street, Marshall, Dowdall, & Riggs, 2007) . have been bothered by somatic complaints over the past four weeks. Items are rated on a scale from 0 ("not bothered at all") to 2 ("bothered a lot") and summed for a total severity score. PHQ-15 scores have shown high internal consistency in samples of civilians (Kroenke et al., 2002) and OEF/OIF veterans (Afari et al., 2015) .
Resilience. The Response to Stressful Experiences Scale (RSES), developed by National
Center for PTSD experts, is a 22-item self-report measure of cognitive, emotional, and behavioral aspects of trait resilience (Johnson et al., 2011) . Respondents rate, on a 0 ("not at all like me") to 4 ("exactly like me") scale, how well each statement describes them. Items are summed to create a total score. RSES scores have shown high internal consistency and good convergent validity with another measure of resilience in a sample of service members and veterans (Johnson et al., 2011) .
Data Analysis Plan and Predictions
Convergent and discriminant validity. We calculated zero-order correlations to Structural validity. Using Mplus version 7.11 (Muthén & Muthén, 2013) , we employed confirmatory factor analysis (CFA) to test the fit of the four-factor DSM-5 model, using pretreatment data. We also examined the structural validity of the PCL-5 by comparing the DSM-5 structure with four alternative factor structures for which there is precedent in the PTSD literature (see Supplemental Material). The five-factor dysphoric arousal model (Elhai et al., 2011 ) labels NACM "numbing" and divides AR into dysphoric arousal and anxious arousal. The six-factor externalizing behaviors model further divides dysphoric arousal into externalizing behaviors and dysphoric arousal; the six-factor anhedonia model maintains anxious and dysphoric arousal but separates avoidance into negative affect and anhedonia; and the sevenfactor hybrid model blends the two six-factor models and comprises intrusions, avoidance, negative affect, anhedonia, externalizing behaviors, anxious arousal, and dysphoric arousal .
For the CFAs, items were specified to load on only one factor, latent factors were allowed to correlate, and error covariances were set to zero. The first item in each factor was set equal to 1 to identify the model, with the exception of the third factor. We selected Item 11 as the marker variable per Keane and colleagues (2014) , because Item 8 (psychogenic amnesia) tends to load poorly on this factor (Miller et al., 2013) . Model fit was determined using the following goodness-of-fit indices: chi-square, root mean square error of approximation (RMSEA), comparative fit index (CFI), Tucker Lewis index (TLI), and standardized root mean square residual (SRMR). CFI and TLI scores above .95, RMSEA values less than .06, and SRMR values less than .08 were interpreted to indicate close fit (Hu & Bentler, 1999) . Relative model fit was assessed with chi-square difference tests for nested models and the Akaike information criterion (AIC) and Bayesian information criterion (BIC) for non-nested models. Differences of greater than 10 points between AIC and BIC values were interpreted to indicate that the model with the lower value more closely fit the data (Burnham & Anderson, 2004) .
Sensitivity to clinical change. We conducted two sets of analyses to assess the PCL-5
scores' sensitivity to clinical change, relative to the PSS-I, using completers from a single First, we assessed pairwise agreement between the PCL-5 and PSS-I in identifying various magnitudes of change using arbitrary cut points. We chose change cut points of 5, 10, 15, and 20 points for both scales and categorized participants as improved or not improved (i.e., the score decreased by the cut point, or did not). Then, we calculated the agreement between the scales, within categorizations, and calculated the percentage of cases in agreement. Cases in agreement were defined as those for which changes on the PCL-5 and PSS-I were either both above or both below the cut point. In addition, we calculated the Pearson correlation and concordance correlation coefficients of pre-and post-treatment PCL-5 and PSS-I change scores, the latter reflecting the extent to which the change scores were of equal magnitude.
Second, we assessed pairwise agreement between the PCL-5 and PSS-I in classifying individuals according to strict criteria for defining statistically reliable and clinically meaningful change. Following Jacobson and Truax's (1991) method, we established reasonable cut scores between the dysfunctional and functional populations using their suggested cut score A, defined as the point that is two standard deviations beyond the range of the pre-therapy mean. Next, we calculated a reliable change index (RC) for each participant to ensure that changes were not attributable to chance or measurement error. The RC is computed as (x2 -x1)/Sdiff where x1
represents the participant's pretreatment PCL-5 or PSS-I total score, x2 represents the participant's posttreatment total score, and Sdiff is the standard error of difference between the two test scores. Sdiff was calculated based on test-retest reliabilities (rxx) available for the measures. For the PCL-5, 30-day rxx = .84 (Bovin et al., 2015) , and for the PSS-I, rxx = .80 (Foa et al., 1993 ). An RC larger than 1.96 reflects statistically reliable change. Based on the two-step criterion, individuals were classified as recovered (passed both cut score A and RC criterion), Diagnostic utility. Using Kraemer's (1987 Kraemer's ( , 1992 signal detection methodology, we generated optimally efficient cut scores for the PCL-5 relative to PTSD diagnosis according to DSM-IV and DSM-5 criteria, using various measures and scoring rules. In addition to using the PSS-I-based PTSD caseness rules described above, we selected cut scores of 39 (Dickstein et al., 2015), 44, and 50 (McDonald & Calhoun, 2010) to indicate a positive screen for PTSD on the PCL-S. We also generated optimally efficient cut scores for the PCL-S relative to the PCL-5 DSM-5-based (moderate or above) caseness rule. Optimally efficient scores maximize the number of agreements between test and diagnosis (i.e., minimize the number of false negatives and false positives).
Results
Descriptive Characteristics of the Sample
Descriptive characteristics of the sample are reported in Table 1 . The mean age was 33
years, and the sample was diverse in race and military role. Most participants were male, were married, had completed some college, and were active duty enlisted personnel. Nearly all had deployed at least once to Iraq or Afghanistan, and they had, on average, last returned from deployment two years prior to completing the baseline assessment.
PTSD severity varied somewhat according to demographics and warzone exposure. .51) than those who were in combat support (e.g., security; M = 18.61, SD = 9.98) or combat service support (e.g., mechanic; M = 18.49, SD = 9.12) roles, F(2, 468 ) = 3.71, p = .025.
Base rates of PTSD according to various definitions (see Method) are reported in Table 3 and ranged from 51% using the stringent PSS-I scoring rule to 84% using the lenient PSS-I scoring rule. High rates were expected because of the treatment-seeking nature of the sample.
The agreement between various scoring rules for PTSD caseness and a positive diagnosis on the PCL-5 using the DSM-5 scoring rule is reported as kappa values in Table 3 . Agreement with the PCL-5 was highest for the PCL-S, moderate for the PSS-I using the lenient scoring rule, and lowest for the PSS-I using the stringent scoring rule.
Descriptive Characteristics of PCL-5 Scores
We report means and standard deviations for PCL-5 scores and all other study variables in 
Internal Consistency
As shown in Table 2 , the PCL-5 overall severity and subscale scores demonstrated high internal consistency at baseline and follow-up, with Cronbach's alpha values ranging from .75
for the AR subscale at baseline to .95 for the overall scale at follow-up. Inter-item correlations were analyzed as an additional index of internal consistency. In general these fell in the recommended range of .15 to .50 (Clark & Watson, 1995) , with a range of .10 to .74 (M = .33).
Validity
Convergent and discriminant validity. We present predicted and observed correlations between PCL-5 scores and scores on criterion measures in Table 5 .
Comparing the nested models, the six-factor anhedonia and six-factor externalizing behaviors models fit the data better than the four-factor DSM-5 model, ∆ χ² (7) Table 6 show agreement between the PCL-5
Sensitivity to clinical change. Results in
and PSS-I in identifying pre-post changes of various magnitudes (i.e., 5-to 20-point improvements). Kappas ranged from .28 to .55, and the percentage of cases in agreement ranged from 72% for the 5-point change to 82% for the 15-point change. The Pearson correlation coefficient between the PCL-5 and PSS-I pre-post change scores was .72, and the concordance correlation coefficient was .68, indicating that the change scores were highly correlated and of nearly equal magnitude.
Results in Table 7 show agreement between PCL-5 and PSS-I in identifying statistically 
Diagnostic Utility
In Table 8 , we provide optimally efficient cut scores on the PCL-5 relative to PTSD diagnosis according to DSM-IV and DSM-5 criteria, using various measures and scoring rules. A PCL-5 score of 33 and a PCL-S score of 43 were found to be optimally efficient for detecting PTSD cases according to PCL-5 DSM-5 scoring criteria. PCL-5 scores of 36, 23, and 42 were found to be optimally efficient for detecting PTSD cases according to PCL-S DSM-IV scoring, PSS-I lenient scoring, and PSS-I stringent scoring criteria, respectively. PCL-5 scores of 25, 31, and 39 were found to be optimally efficient in corresponding to PCL-S cut scores of 39, 44, and 50, respectively.
Discussion
As criteria for PTSD have evolved, the PCL required revision to be consistent with DSM-5. We examined the psychometric properties of the PCL-5 in a large cohort (N = 912) of service members seeking treatment for PTSD while stationed in garrison (i.e., their permanent duty station). The PCL-5 scores were found to be psychometrically sound when evaluated in a clinical setting with high base-rates for PTSD. The PCL-5 total and subscale scores were found to have high internal consistency. In terms of construct validity, effect size estimates indicated that predicted correlations, based on published research with the PCL-S, strongly matched observed correlations between the PCL-5 and criterion measures. As expected, the largest positive correlation emerged between PCL-5 scores and PCL-S scores, as they share most items (see Hoge et al., 2014) as well as method variance. The next largest correlation was with the clinician-administered measure of PTSD, suggesting strong convergent validity. Correlations with measures of other constructs were weaker and followed the predicted pattern. Shared method (i.e., self-report) variance may have inflated correlations.
The correlations between scores on the PCL-5 and scores on the Combat Experiences and
Aftermath of Battle subscales of the DRRI were smaller than predicted. The predicted correlations (rs = .30) were based on the DRRI validation study, which used a prior version of the PCL that did not require symptoms to be indexed to a specific Criterion-A index event (Vogt et al., 2008) . The strength of the relationship between the DRRI exposure subscales and PCL severity has been considerably smaller in studies that have asked service members to index their PTSD symptoms to a single Criterion-A event (e.g., Nash et al., 2015) . When, as in the present study, all participants have had sufficient exposure to warrant a PTSD interview, and they are furthermore required to index their PTSD symptoms to a single event, the expectation of a moderate dose-response relationship between broad exposure scales and PTSD symptom severity should be reconsidered.
Consistent with existing evaluations of the PCL-5 factor structure, the DSM-5 model had only adequate fit (Kline, 2005) . In fact, no previously evaluated alternative factor structure was found to have close fit in this study. Nevertheless, a seven-factor model showed superior fit to the DSM-5 model and other variations, which is consistent with Armour et al. (2015) . It may be necessary to reconsider the DSM-5 symptom factors (clusters) if they consistently fail to be empirically validated. Alternatively, it could be difficult to replicate the putative sub-components of DSM-5-defined PTSD with a self-report measure; DSM-5-based structured clinical interviews may fare better.
The PCL-5 was comparable to an interview-based assessment of PTSD symptoms in terms of sensitivity to clinical change (pre-to post-treatment). PCL-5 and PSS-I scores showed a fair to moderate correspondence in categorizing change based on arbitrary cut points and high concordance between pre-post change scores. Using the conservative Jacobson and Truax (1991) method to categorize individuals based on reliable and clinically significant change, there was moderate agreement between the PCL-5 and PSS-I. The measures agreed most in classifying individuals who did not change or showed clinically significant improvement. The PCL-5's classification of a smaller number of individuals into the clinically significant improvement category suggests that it may be more conservative than the PSS-I in identifying clinically meaningful change.
A thorough examination of substantive and clinically meaningful change on the PCL-5 was beyond the scope of this effort. That would require clinician or patient judgments and referencing scores to healthy outcomes (Jacobson, Roberts, Berns, & McGlinchey, 1999; Jacobson & Truax, 1991; Kraemer et al., 2003) . Other researchers have proposed simpler methods for indexing clinically significant change (e.g., 0.5 SD; Norman, Sloan, & Wyrwich, 2003) . Monson et al. (2008) reported clinically significant change on a DSM-IV version of PCL to be 10 points, stating that they used the Jacobson and Truax method. However, it is unclear what these authors used to index healthy scores on the PCL, and they did not specify the formulas used to derive this result, given that the Jacobson and Truax method results in a cut score as opposed to a change-score. When the range of scores typical of the healthy population is unknown, Jacobson and Truax (1991) recommend a conservative strategy to estimate clinically meaningful change, which entails calculating a cut score that is two standard deviations below mean baseline scores for patients entering a clinical trial. In this study, this approach yielded a score of 24; for service members getting treatment for PTSD while in garrison, posttreatment scores at or below 24 on the PCL-5 likely represent clinically significant change, provided their reliable change index also exceeds 1.96 (see Jacobson & Truax, 1991) . We provide this information with a note of caution. It is difficult to draw conclusions from this variation of the That we could not evaluate order effects of the presentation of the PCL versions is a significant limitation of this study. Ideally, the PCL-S and PCL-5 presentation order would have been counterbalanced (as in Hoge et al., 2014) , with both measures presented prior to the PSS-I to minimize carryover effects from the interview to the self-report measures. We also could not assess the test-retest reliability of the PCL-5, because the PCL-5 was administered once at baseline and again after treatment. Although there is no reason to suspect poor performance in this area (e.g., the PCL-S showed adequate test-retest reliability, Wilkins et al., 2011) , future studies should assess this characteristic of the PCL-5.
In summary, we found the PCL-5 to have very sound psychometric properties overall, although, consistent with prior research, the factor structure of the scale did not conform optimally to any existing proposed factor structure. The results of this psychometric analysis of PCL-5 scores are not generalizable to contexts where the base rates for PTSD are lower than our study, and the properties of the PCL-5 scores, particularly cut scores for screening and diagnosis, are also likely to vary by sample and context (see McDonald & Calhoun, 2010) . Consequently, our results are chiefly applicable to clinical settings that treat active duty military service members and new veterans seeking care for PTSD. Table 2 The five-factor model compared to the four-factor model, both six-factor models compared to the five-factor model, and the seven-factor model compared to the six-factor anhedonia model. PCL-5 = PTSD Checklist for DSM-5; DSM-5 = fifth edition of the Diagnostic and Statistical Manual of Mental Disorders; RMSEA = root mean square error of approximation; CFI = comparative fit index; TLI = Tucker Lewis index; SRMR = standardized root mean square residual; AIC = Akaike information criterion; BIC = Bayesian information criterion. Percentage of cases in agreement are those for which changes on the PCL-5 and PSS-I are either both above or both below the cut point. Discordant pairs have one change score above and the other below the cut point. The kappa statistic, κ, has standard error, SE. to decimal places shown. PCL-5 = PTSD Checklist for DSM-5; PCL-S = PTSD Checklist specific stressor version for DSM-IV; PTSD = posttraumatic stress disorder; Level = level of test (i.e., % of participants meeting cutoff); PPV = positive predictive value; NPV = negative predictive value; Eff = efficiency; к (0) = quality of specificity; к (.5) = quality of efficiency; к (1) = quality of sensitivity; AUC = area under the curve; DSM-5 = fifth edition of the Diagnostic and Statistical Manual of Mental Disorders; DSM-IV = fourth edition of the Diagnostic and Statistical Manual of Mental Disorders; PSS-I = PTSD Symptom Scale -Interview version. Confidence intervals provided for к (.5). Measures of test quality are adjusted for chance agreement between the test and criterion. These values range from .00 (chance agreement) to 1.00 (perfect agreement).
